Good news for those who are developing a vaccine: The new TRANSVAC TNA 2006-09 is now open and will last until August 5th. TRANSVAC2 offers technical services at all stages of the vaccine R&D pipeline to support the development of prophylactic and therapeutic vaccines for human and veterinary use. Researchers, Public institutions, SME’s & Industry can apply for free for high-quality technical R&D services covering all aspects of vaccine development, for:
- Any disease
- Prophylactic and therapeutic vaccines
- Human and veterinary vaccines
- Free of charge (with few exceptions)
TRANSVAC2 is a EU H2020 funded project, dedicated to accelerate vaccine candidates across the R&D pipeline, by offering technical services to vaccine developers in academic and industry settings. The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.